Externally validated AI-driven multimodal prediction of progression from Stage B (asymptomatic LV dysfunction) to overt heart failure: incremental prognostic value of GLS and NT-proBNP

28 August 2026 (11:25 - 11:35)
Organised by: Logo
Congress Presentation Part of: The future of heart failure care: artificial intelligence, biomarkers, early detection and beyond Biomarkers ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology